Frazier Healthcare Partners Adds Highly Experienced Pharma Executive to Growth Buyout Team
Cencora, Inc. (COR)
Last cencora, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.coresite.com/investor-overview
Company Research
Source: Business Wire
SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, is pleased to announce that Willis Chandler has joined the firm’s Growth Buyout team as an Executive in Residence. Mr. Chandler will work alongside the firm to develop and execute investment strategies focused on pharma and pharmacy services. In this role, he will focus on the sourcing, diligence, and leadership of a new platform investment for Frazier.“The secular growth in pharma and pharmacy services has been an area of focus for Frazier for several years, and we are thrilled to welcome an industry veteran like Willis to our team,” said Nathan Every, General Partner at Frazier. “We are confident that his extensive leadership experience will be of great value as we partner with him to invest in this space.”“I have long admired the way Frazier’s Growth Buyout team approaches sourcing and growing promising healthcare companies, and I am thrilled to be joinin
Show less
Read more
Impact Snapshot
Event Time:
COR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COR alerts
High impacting Cencora, Inc. news events
Weekly update
A roundup of the hottest topics
COR
News
- Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Robert W. Baird from $287.00 to $292.00. They now have an "outperform" rating on the stock.MarketBeat
- Cencora, Inc. (NYSE: COR) had its price target raised by analysts at UBS Group AG from $275.00 to $285.00. They now have a "buy" rating on the stock.MarketBeat
- Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Barclays PLC from $263.00 to $290.00. They now have an "overweight" rating on the stock.MarketBeat
- Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Evercore ISI from $250.00 to $285.00. They now have an "outperform" rating on the stock.MarketBeat
- Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results [Yahoo! Finance]Yahoo! Finance
COR
Earnings
- 11/6/24 - Beat
COR
Sec Filings
- 11/8/24 - Form 8-K
- 11/6/24 - Form 8-K
- 11/5/24 - Form 4
- COR's page on the SEC website